Dopa-responsive, nonprogressive, juvenile parkinsonism: Report of a case

Movement Disorders

Volumn 12, Issue 3, 1997, Pages 453-456

  Rajput, A ^a   Kishore, A ^a   Snow, B ^a   Bolton, C F ^a   Rajput, A H ^a  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; CARBIDOPA PLUS LEVODOPA; LEVODOPA;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DYSKINESIA; HUMAN; MALE; ONSET AGE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030926851     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120332     Document Type: Article

References (45)

1. 1 Rajput AH, Offord KP, Beard CM, Kurland LT. Epidemiology of parkinsonism: Incidence, classification, and mortality. Ann Neurol 1984 ; 16: 278–282.
2. 2 Rajput AH, Rozdilsky B, Rajput Alex H. Accuracy of clinical diagnosis in parkinsonism—A prospective study. Can J Neurol Sci 1991 ; 18: 275–278.
3. 3 Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico‐pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992 ; 55: 181–184.
4. 4 Duvoisin R, Golbe LI. Toward a definition of Parkinson's disease. Neurology 1989 ; 39: 746.
5. 5 Rajput AH. Frequency and cause of Parkinson's disease. Can J Neurol Sci 1992 ; 19: 103–107.
6. 6 Rajput AH. Parkinsonism, aging and gait apraxia. In: Stern MB, Koller WC, eds. Parkinsonian syndromes. New York: Marcel Dekker, 1993: 511–532.
7. 7 Uitti RJ, Rajput AH, Offord KP. Parkinsonism survival in the levodopa era. Neurology 1991 ; 41 (suppl 1): 190.
8. 8 Quinn N, Critchley P, Marsden CD. Young onset Parkinson's disease. Mov Disord 1987 ; 2: 73–91.
9. 9 Muthane UB, Swamy HS, Satishchandra P, Subhash MN, Rao S, Subbakrishna D. Early onset Parkinson's disease: Are juvenile‐ and young‐onset different? Mov Disord 1994 ; 9: 539–544.
10. 10 Giovannini P, Piccolo I, Genitrini S, et al. Early‐onset Parkinson's disease. Mov Disord 1991 ; 6: 36–42.
11. 11 Lima B, Neves G, Nora M. Juvenile parkinsonism: clinical and metabolic characteristics. J Neurol Neurosurg Psychiatry 1987 ; 50: 345–348.
12. 12 Ludin SM, Ludin HP. Is Parkinson's disease of early onset a separate disease entity? J Neurol 1989 ; 236: 203–207.
13. 13 Gibb WRG, Lees AJ. A comparison of clinical and pathological features of young‐ and old‐onset Parkinson's disease. Neurology 1988 ; 38: 1402–1406.
14. 14 Gibb WRG, Narabayashi H, Yokochi M, Iizuka R, Lees AJ. New pathologic observations in juvenile onset parkinsonism with dystonia. Neurology 1991 ; 41: 820–822.
15. 15 Takahashi H, Ohama E, Suzuki S, et al. Familial juvenile parkinsonism: Clinical and pathologic study in a family. Neurology 1994 ; 44: 437–441.
16. 16 Golbe LI. Young‐onset Parkinson's disease: A clinical review. Neurology 1991 ; 41: 168–173.
17. 17 Nygaard TG, Takahashi H, Heiman GA, Snow BJ, Fahn S, Calne DB. Long‐term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa‐responsive dystonia. Ann Neurol 1992 ; 32: 603–608.
18. 18 Nygaard TG, Duvoisin RC. Hereditary dystonia‐parkinsonism syndrome of juvenile onset. Neurology 1986 ; 36: 1424–1428.
19. 19 Harwood G, Hierons R, Fletcher NA, Marsden CD. Lessons from a remarkable family with dopa‐responsive dystonia. J Neurol Neurosurg Psychiatry 1994 ; 57: 460–463.
20. 20 Nygaard TG, Marsden CD, Fahn S. Dopa‐responsive dystonia: Long‐term treatment response and prognosis. Neurology 1991 ; 41: 174–181.
21. 21 Vingerhoets FJG, Snow BJ, Lee CS, Schulzer M, Mak E, Calne DB. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Ann Neurol 1994 ; 36: 759–764.
22. 22 Lee CS, Schulzer M, Mak EK, et al. Clinical observations on the rate of progression of idiopathic parkinsonism. Brain 1994 ; 117: 501–507.
23. 23 Rajput AH, Stern W, Laverty WH. Chronic low dose therapy in Parkinson's disease: An argument for delaying levodopa therapy. Neurology 1984 ; 34: 991–996.
24. 24 Marsden CD, Parkes JD. Success and problems of long‐term levodopa therapy in Parkinson's disease. Lancet 1977 ; 1: 345–349.
25. 25 Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967 ; 17: 427–442.
26. 26 Vingerhoets FJG, Snow BJ, Schulzer M. Reproducibility of fluorine‐18–6‐fluorodopa positron emission tomography in normal human subjects. J Nucl Med 1994 ; 35: 18–23.
27. 27 Bailey DL, Meikle SR. A convolution‐subtraction scatter correction method for 3D PET. Phys Med Biol 1994 ; 39: 411–424.
28. 28 Kinahan PE, Rogers JG. Analytic 3D image reconstruction using all detected events. IEEE Trans Nucl Sci 1989 ; 36: 964–968.
29. 29 Agid Y. Parkinson's disease: Pathophysiology. Lancet 1991 ; 337: 1321–1324.
30. 30 Scott RM, Brody JA. Benign early onset of Parkinson's disease: A syndrome distinct from classic postencephalitic parkinsonism. Neurology 1971 ; 21: 366–368.
31. 31 Gerstenbrand F, Poewe WH. The classification of Parkinson's disease. In: Stern GM, ed. Parkinson's disease. Baltimore: The John Hopkins University Press, 1990: 315–331.
32. 32 Selby G. Clinical features. In: Stern G, ed. Parkinson's disease. Baltimore: The John Hopkins University Press, 1990: 333–388.
33. 33 Golbe LI, Lazzarini AM, Schwarz KO, Mark MH, Dickson DW, Duvoisin RC. Autosomal dominant parkinsonism with benign course and typical Lewy‐body pathology. Neurology 1993 ; 43: 2222–2227.
34. 34 Sacks OW. Postencephalitic syndromes. In: Stern G, ed. Parkinson's disease. Baltimore: The John Hopkins University Press, 1990: 415–429.
35. 35 Rajput AH, Uitti RJ, Sudhakar S, Rozdilsky B. Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei. Ann Neurol 1989 ; 25: 602–606.
36. 36 Rajput AH, Gibb WRG, Zhong XH, et al. Dopa‐responsive dystonia: Pathological and biochemical observations in a case. Ann Neurol 1994 ; 35: 396–402.
37. 37 Furukawa Y, Shimadzu M, Rajput AH, et al. GTP‐cyclohydrolase I gene mutations in hereditary progressive and dopa‐responsive dystonia. Ann Neurol 1996 ; 39: 609–617.
38. 38 Takahashi H, Levine RA, Galloway MP, Snow BJ, Calne DB, Nygaard TG. Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa‐responsive dystonia. Ann Neurol 1994 ; 35: 354–356.
39. 39 Snow BJ, Okada A, Martin WRW, Duvoisin RC, Calne DB. PET scanning in dopa‐responsive dystonia, parkinsonism‐dystonia, and young‐onset parkinsonism. In: Segawa M, ed. Hereditary progressive dystonia (with marked fluctuations). Carnforth: Parthenon Publishing, 1993: 181–186.
40. 40 Snow BJ, Nygaard TG, Takahashi H, Calne DB. Positron emission tomographic studies of dopa‐responsive dystonia and early‐onset idiopathic parkinsonism. Ann Neurol 1993 ; 34: 733–738.
41. 41 Turjanski N, Bhatia K, Burn DJ, Sawle GV, Marsden CD, Brooks DJ. Comparison of striatal 18 F‐dopa uptake in adult‐onset dystonia‐parkinsonism, Parkinson's disease, and dopa‐responsive dystonia. Neurology 1993 ; 43: 1563–1568.
42. 42 Sawle GV, Playford ED, Brooks DJ. Asymmetric pre‐synaptic and post‐synaptic changes in the striatal dopamine projection in dopa naive parkinsonism. Brain 1993 ; 116: 853–867.
43. 43 Rinne UK, Laihinen A, Rinne JO. Positron emission tomography (PET) demonstrates dopamine D‐2 receptor supersensitivity in the striatum of patients with early Parkinson's disease. Mov Disord 1989 ; 5: 55–59.
44. 44 Brooks DJ, Ibanez V, Sawle GV, et al. Striatal D 2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11 C‐raclopride and positron emission tomography. Ann Neurol 1992 ; 31: 184–192.
45. 45 Hagglund J, Aquilinoius SM, Eckernas SA. Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C‐N‐methyl‐spiperone. Acta Neurol Scandinav 1987 ; 75: 87–94.